LEADING MEDICINE FORWARD Trademark

Trademark Overview


On Thursday, August 22, 2024, a trademark application was filed for LEADING MEDICINE FORWARD with the United States Patent and Trademark Office. The USPTO has given the LEADING MEDICINE FORWARD trademark a serial number of 98711644. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 5, 2025. This trademark is owned by FWD Clinical Research. The LEADING MEDICINE FORWARD trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

CLINICAL RESEARCH COMPANY, WE CONDUCT CLINICAL TRIALS FOR PHARMACEUTICAL COMPANIES.
leading medicine forward

General Information


Serial Number98711644
Word MarkLEADING MEDICINE FORWARD
Filing DateThursday, August 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCLINICAL RESEARCH COMPANY, WE CONDUCT CLINICAL TRIALS FOR PHARMACEUTICAL COMPANIES.

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code044
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateFriday, January 1, 2021

Trademark Owner History


Party NameFWD Clinical Research
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTAMARAC, FL 33321

Trademark Events


Event DateEvent Description
Thursday, August 22, 2024NEW APPLICATION ENTERED
Thursday, August 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 27, 2025ASSIGNED TO EXAMINER
Wednesday, March 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 5, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED